Cargando…
Suppression of lung cancer in murine model: treated by combination of recombinant human endostsatin adenovirus with low-dose cisplatin
BACKGROUND: The sustained growth of tumors necessitates neovascularization. As one of the potent endogenous vascular inhibitors, endostatin has been widely used in antiangiogenesis therapy for tumor. Cisplatin is normally administered in chemotherapy for lung cancer but accompanied with serious side...
Autores principales: | Bai, Rui Z, Wu, Yang, Liu, Quan, Xie, Ke, Wei, Yu Q, Wang, Yong S, Liu, Kang, Luo, Yan, Su, Jing M, Hu, Bing, Liu, Ji Y, Li, Qiu, Niu, Ting, Zhao, Zhi W, Yang, Li |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2657125/ https://www.ncbi.nlm.nih.gov/pubmed/19265510 http://dx.doi.org/10.1186/1756-9966-28-31 |
Ejemplares similares
-
Low-dose paclitaxel improves the therapeutic efficacy of recombinant adenovirus encoding CCL21 chemokine against murine cancer
por: Chen, Ping, et al.
Publicado: (2014) -
Dendritic cells transduced with TIPE-2 recombinant adenovirus induces T cells suppression
por: Liu, Shudong, et al.
Publicado: (2021) -
Dose Effects of Recombinant Adenovirus Immunization in Rodents
por: Weaver, Eric A.
Publicado: (2019) -
Recombinant adenoviruses expressing apoptin suppress the growth of MCF-7 breast cancer cells and affect cell autophagy
por: Chen, Shuang, et al.
Publicado: (2019) -
Recombinant adenovirus-mediated overexpression of 3β-hydroxysteroid-Δ24 reductase
por: Lu, Xiuli, et al.
Publicado: (2014)